Schizophrenia is a severe mental disorder with often a chronic course. Neuroimaging studies report brain abnormalities in both white and gray matter structures. However, the relationship between microstructural white matter differences and volumetric subcortical structures is not known.
Introduction
Schizophrenia is a severe and often debilitating mental disorder with largely unknown disease mechanisms. It is well established that patients with schizophrenia, across different disease states, demonstrate white matter microstructural (1) and gray matter structural (2,3) differences when compared to healthy controls, as well as progressive differences (4) (5) (6) related to the pathophysiology of the disorder and possibly medication use.
Diffusion magnetic resonance imaging (dMRI) and T1-weighted structural imaging are two popular magnetic resonance imaging (MRI) techniques that are often used to study schizophrenia. dMRI, using its popular analysis method -diffusion tensor imaging (DTI) (7) -yields in vivo indirect measures of white matter microstructure (8) such as fractional anisotropy (FA), axial diffusivity (AD) and radial diffusivity (RD). The FA measure is purported to be associated with white matter integrity, and can decrease both due to axonal degeneration and demyelination (6, 9) , indicated by reduced AD and increased RD, respectively (8) . However, the FA measure may not provide a good representation of white matter integrity due to several methodological issues (10) , including partial volume effects e.g. from extracellular water contamination and crossing fibers (8) . The bi-tensor free-water imaging model (11) accounts for extracellular free-water, yielding improved tissue specificity of white matter measures compared to the DTI model (11) . The method also provides a free-water fractional volume measure that is affected by extracellular processes e.g. neuroinflammation, atrophy and cellular membrane breakdown (12) .
The largest DTI meta-analysis to date showed that patients with schizophrenia have widespread white matter FA reductions compared to controls, with regionally more severe differences with increasing illness duration (1) . Cross-sectional free-water imaging studies in schizophrenia corroborate increasing tissue change with illness duration; At schizophrenia onset, reports indicate limited tissue change together with widespread increase in free-water (13, 14) , while with chronicity there is evidence of widespread tissue changes together with limited free-water increase (12, 15 ) when compared to healthy controls. These findings could indicate a severity gradient and that the temporal disease state needs to be considered in schizophrenia studies of microstructural white matter.
Structural MRI studies of patients with schizophrenia have shown widespread cortical thinning (3, 16, 17) , area reduction (3, 17) , folding abnormalities (18) and alterations of subcortical volumes, including smaller hippocampus and amygdala, and larger basal ganglia volumes (2, 16, 19) , compared to healthy controls. Longitudinal studies have indicated, although somewhat inconclusively, increasing cortical thinning with illness duration (4) . A recent large cross-sectional study showed enlargement of the putamen and pallidum volumes with age and illness duration (2). Microstructural white matter differences in schizophrenia indicated by reduced FA have been linked to cortical thinning in temporal regions, cuneus, frontal gyrus, orbitofrontal cortex (20) , and cingulate cortex (21) . Recently cortical thinning was also inversely associated with infracortical white matter anisotropy in adult patients (<50 years of age) (22) . A single study showed increased mean diffusivity of the left accumbens, and the hippocampus and thalamus bilaterally, in patients (23) . This could indicate patterns of associations between brain regions that are limited to patients with schizophrenia.
In the present study we investigated white matter diffusion properties using the free-water imaging method. The aims of the study were to: (i) identify differences in microstructural white matter diffusion properties between long-term treated patients with schizophrenia and healthy controls, (ii) investigate putative associations between medication or clinical symptoms on white matter microstructure in patients, and (iii) investigate whether volumetric measures of subcortical structures were associated with observed patient-control differences in white matter microstructure. In line with prior free-water imaging studies, we expected to observe microstructural white matter differences in patients with chronic schizophrenia together with limited evidence of increased free-water (12, 15) , and clinical symptoms to be linked with microstructural white matter in patients (15) . We hypothesized that white matter microstructure could be associated with medication use in line with prior DTI studies (24, 25) , and that patient microstructural white matter differences are linked with volumetric subcortical measures, similar to prior cortical findings (20, 21) .
Materials and Methods

Study Population
The subject sample consisted of 30 patients (Schizophrenia [N=22], Schizoaffective disorder [N=8]) and 42 controls, recruited among participants from the HUBIN study at the Karolinska Hospital (18,26), and investigated between 2011 and 2015. Exclusion criteria for all participants were age 18 or 70 years, IQ70, or previous severe head injury. All participants received oral and written information about the study and signed a written informed consent. The study was approved by the Research Ethics Committee at Karolinska Institutet, Sweden, and was conducted in accordance with the Helsinki declaration.
Clinical Assessment
Patients and controls were assessed by a psychiatrist (EGJ) using the Structured Clinical Interview for DSM-III-R axis I disorders (27) . Diagnosis was based on DSM-IV (28) . Symptoms were assessed according to the Scale for the Assessment of Negative Symptoms (SANS) (29) and the Scale for the Assessment of Positive Symptoms (SAPS) (30) . Psychosocial functioning was assessed using the split version of the Global Assessment of Function (GAF-S and GAF-F) scale (31) . Age at onset was defined as the age of first verified positive psychotic symptom experience and duration of illness was calculated in years from age at onset to age at MRI. Chlorpromazine equivalent antipsychotic dose (CPZ) was computed (32).
Data acquisition
Patients and controls underwent MRI on the same 3 T General Electric Healthcare Discovery MR750 
MRI Processing
All dMRI's were processed as follows: Brain masks of the first b0 volume were manually edited to remove non-brain tissue. The dMRI's were corrected for eddy current induced distortions and subject head motion using FSLs EDDY (33) . We enabled automatic detection and correction of motion induced signal dropout (34) , previously shown to enhance signal-to-noise ratio (35) . EDDY outputs rotated bvectors used in subsequent processing and total per-volume-movement used to calculate the average motion. Following EDDY correction, a bi-tensor diffusion model was fitted using a nonlinear regularized fit to obtain a free-water corrected diffusion tensor representing the tissue compartment and the fractional volume of an isotropic free-water compartment (11) . From the diffusion tensor, a tissue specific scalar measurement of fractional anisotropy (FAt) was derived using FSLs dtifit. FAt depends on two independent measures, radial diffusivity (RDt) and axial diffusivity (ADt), and they were derived for an additional level of investigation. The scalar measurements of each subject were projected onto a standard FA skeleton using Tract-Based Spatial Statistics (TBSS) (36) . To do so, the FA images were registered to the ENIGMA-DTI FA template (37) that aligns with the Johns Hopkins University (JHU) DTI atlas (38) following the ENIGMA-DTI processing protocols (http://enigma.ini.usc.edu/protocols/dtiprotocols/). Forty-four regions of interests (ROIs; Table 1 ) were extracted. The standard DTI measures of AD, RD and mean diffusivity (MD) were also derived and projected onto the FA skeleton.
All T1-weighted MRI scans were processed using FreeSurfer (39) version 6.0.0. The processing steps include motion correction, bias field correction, brain extraction, intensity normalization and automatic Talairach transformation, with optimized 3T bias field filtration (40). Subcortical volumes were obtained through the subcortical segmentation stream (41) , except for the hippocampus and amygdala structures obtained through joint segmentation in FreeSurfer version 6.0.0, development version (42,43). The extracted bilateral subcortical structures were: hippocampus, amygdala, thalamus, nucleus accumbens, caudate, pallidum, putamen and lateral ventricle.
MRI Quality control
Only dMRI's and volumetric structures passing quality control were included in the analyses. Initially there were 80 participants in the study.
All DWIs were visually inspected in three orthogonal views for severe visible artifacts (44) , leading to the exclusion of 4 participants. Additionally, we excluded 4 subjects with an EDDY estimated average motion above two standard deviations from the mean. After quality control there were 72 participants in the study.
All T1-weighted images were visually inspected for movement and cortical segmentation errors. No participants needed to be excluded at this stage. The segmentation quality of the subcortical volumes was assessed by manual inspection of outlier volumes (defined as: 1.5 times interquartile range).
Outlier volumes were excluded if the segmentation was inaccurate. This led to the exclusion volumes from 4 participants, namely: one volume each for the left amygdala, left thalamus, left putamen, right putamen, right accumbens, and right caudate.
Statistical method
The demographic variables of patients and controls were compared using  2 -test for categorical variables, two-sample t-test/two-sided Wilcoxon rank-sum test for normally/non-normally distributed continuous variables. Normality was assessed using the Shapiro-Wilk's normality test (45) .
In the main analyses, we applied multiple linear regression to assess the effect of patient-control differences on each white matter ROIs using the lm-function in R (version 3.5.0). For comparison, we included analyses using both the free-water imaging and standard DTI method. In patients, we further investigated free-water imaging metrics for the effects of medication and clinical symptoms on each ROI using similar models. For all models we adjusted for sex, age, and average movement.
We conducted follow-up analyses for ROIs showing significant patient-control differences to assess potential associations between white matter microstructure and volumetric measures of subcortical structures. To do so, we extended the main model to include a term for the subcortical volumes and its interaction with patient status. To capture associations between white matter microstructure and subcortical volumes, independent of size, we chose not to include ICV in the model.
We computed Cohen's d effect size from the t-statistics for categorical variables, and via the partial correlation coefficient, r, for continuous variables (46) . We corrected for multiple comparisons using the false discovery rate (FDR) at =0.05 (47) across planed analyses, yielding significance threshold p0.0109. For follow-up analyses, a separate FDR threshold was computed at p0.0116.
Results
Demographic and Clinical Data
Patients had an average age of onset (AAO) of 23.5±4.6 years and an average duration of illness of 27.6±8.0 years. Of the patients, 93.3% received antipsychotic medication (8 first generation, 13 second generation, 7 first and second generation) with an average CPZ doze of 409.8±325.2 mg. Compared to the controls, patients had significantly fewer years of education (p=0.0011), and decreased functioning as assessed by GAF symptom (p=6.2e-13) and GAF function (p=1.4e-13) score. During diffusion MRI the patients moved significantly more than the controls (p=0.0298). There were no significant differences in the other clinical or demographic data (Table 2) .
Patient-control differences in diffusion properties
FAt was significantly lower in patients compared to controls in the right anterior corona radiata (ACR) (d=-0.96, p=0.0002), left ACR (d=-0.74, p=0.0040) and left anterior limb of internal capsule (ALIC) (d=-0.69, p=0.0069) ( Figure 1 ; Table S1 ). In those regions, FAt reductions were driven by significantly lower ADt (d=-0.94, d=-0.75 and d=-0.71, respectively) and significantly higher RDt (d=0.94, d=0.71, and d=0.70, respectively). Furthermore, the RDt of the fornix was significantly higher for patients (d=0.82, p=0.0015) without any corresponding significant or nominal-significant differences in FAt or ADt. There were nonsignificant patient-control differences in free-water.
For comparison, running the same analysis using the standard DTI model showed significant differences between patients and controls only for the right ACR (FA: d=-0.88; RD: d=0.66) ( Table S2 ).
Effects of medication
Analyses in patients did not show any significant CPZ medication effects on white matter microstructure ( Table S3 ).
Effects of clinical symptoms
Analyses in patients showed that total SAPS scores were significantly associated with increased freewater on the right posterior thalamic radiation (PTR; d=1.20, p=0.0061) and the left sagittal stratum (SS; d=1.16, p=0.0078), respectively (Table S4 ). Total SANS scores were for the right ALIC significantly associated with decreased FAt (d=-1.14, p=0.0088) and increased RDt (d=1.20, p=0.0061) (Table S5) .
Association between diffusion measures and subcortical volumes
In ROIs with significant diagnostic differences, we conducted follow-up analyses for possible association between free-water imaging diffusion metrics and subcortical volumes identified as significant interaction between subcortical volumes and patient status.
For the left ACR, the FAt reduction in patients was attenuated in the presence of larger measures of hippocampus (left: d=0.77, p=0.0028; right: d=0.69, p=0.0068), right amygdala (d=0.67, p=0.0084), and right thalamus (d=0.68, p=0.0076). Similarly, ADt reduction and RDt increase were attenuated for larger left hippocampus (ADt: d=0.72, p=0.0048; RDt: d=-0.7, p=0.0064) and right thalamus (ADt: d=0.67, p=0.0084; RDt: d=-0.66, p=0.0098). For the free-water compartment, despite non-significant main effect of diagnosis, free-water was attenuated in the presence of larger caudate (left: d=-0.69, p=0.0069; right: d=-0.71, p=0.0057) and left thalamus (d=-0.69, p=0.0075) ( Figure 2 ; Table S6 ).
For the right ACR and left ALIC, despite non-significant main effect of diagnosis, we find associations between free-water and caudate in patients; the free-water compartment was reduced for the right ACR in the presence of larger caudate (left: d=-0.67, p=0.0091; right: d=-0.85, p=0.0012), and for the left ALIC for larger right caudate (d=-0.65, p=0.0111) ( Figure 3 ; Table S7-S8) .
For the fornix, RDt was reduced for larger left nucleus accumbens (d=-0.73, p=0.0044) and hippocampus (left: d=-0.68, p=0.0083; right: d=-0.66, p=0.0100). The free-water compartment was, despite non-significant main effect of diagnosis, significantly associated with right ventricle (d=-0.69, p=0.0071) in patients, but this association appears driven by outliers ( Figure 4 ; Table S9 ).
Discussion
In this study we investigated the relationship between free-water imaging measures and subcortical volumes in patients with long-term treated chronic schizophrenia. The main findings were localized lower white matter anisotropy in patients compared with healthy controls, but no differences in freewater. White matter microstructure was linked with subcortical volumes in differing patterns for patients and controls.
The observed reduction in FAt, driven by a combination of ADt reduction and RDt increase, could indicate a pattern of axonal degeneration and demyelination in the frontal white matter in long-term treated chronic schizophrenia patients when compared to controls. In the fornix, the increased RDt without simultaneous reduced FAt and ADt could imply demyelination without axonal degeneration in the patients. The free-water imaging method was more sensitive to patient-control differences in white matter microstructure than the standard DTI model. Our findings were similar to and partly overlapping with previous free-water imaging studies indicating reduced FAt in cross-hemisphere frontal white matter in patients with schizophrenia (12) (13) (14) (15) , and no free-water increase in the chronic state (12, 15) . The FAt changes were more pronounced than the reported changes in first episode patients (13, 14) . However, the FAt changes were not as widespread as the previously reported changes in chronic schizophrenia (12, 15) . The differences could be due to the limited sample size in the current study, but could also reflect that our long-term treated chronic schizophrenia sample on average had been ill for 27 years. This is longer than the previous studies, and it is not clearly known how the disorder progress with age and illness duration as captured by dMRI.
The observed interactions between patient status and subcortical structures on white matter microstructure for both the left ACR and the fornix, indicate patterns of association between the structures that are different in patients with chronic schizophrenia compared to controls. This is in line with previous studies that show cortical thinning in relation to white matter changes in patients with schizophrenia (20) (21) (22) . The results may suggest that volumetric properties of brain anatomical structures are related to disrupted white matter microstructure in schizophrenia. The findings were in the direction of larger subcortical structures being associated with less severe white matter changes in patients with chronic schizophrenia, or vice versa. This could point towards a severity gradient in structural changes where less pronounced microstructural changes in patients have weaker diagnosis specific links to subcortical structures. They could also indicate disease specific patterns of associations between subcortical structures and microstructural white matter properties in chronic schizophrenia, and of disrupted functioning of the limbic system (48) and prefrontal connections (49) . The reported findings are in line with the hypothesis of schizophrenia being a disorder of dysconnectivity (50) (51) (52) .
It is well established that the limbic system plays a role in schizophrenia, and subcortical structures of the limbic system have previously been reported as reduced in schizophrenia (2). The current study provides further support for limbic system involvement in the disorder together with links to white matter structures, which need to be further investigated.
We did not find any general patient-control differences in free-water. Despite this, in the follow-up analyses we found evidence of diagnosis specific involvement between free-water and some subcortical structures, and particularly larger caudate. Thus, there could be diagnosis specific association patterns between free-water and subcortical structures, but the implications of this is unknown. We can only speculate that the association could be linked to e.g. better functioning or reduced inflammatory state, but this needs to be further investigated. These findings warrants replication in larger samples.
Among patients, positive symptoms were significantly associated with increased free-water in the right PTR and left SS. Similarly, negative symptoms were associated with reduced FAt and increased RDt in the right ALIC. This is in line with a prior study indicating that positive symptoms are associated with increased free-water and negative symptoms with reduced FAt (15) . Furthermore, negative and positive symptoms were previously linked to changes in white matter microstructure using standard DTI (1) . The association between microstructural white matter and clinical symptoms needs further investigation.
We did not observe any CPZ medication effects on white matter microstructure, which is in line with prior research (1) . However, given the long-term treatment of the patients in the current study we cannot rule out that the observed effects on brain structure is due to antipsychotic medication, although not captured by CPZ. First and second generation antipsychotic medication could be differently involved with brain structure as previously shown for basal ganglia structures (53) . How this relates to white matter microstructure needs to be addressed in a larger sample.
There are some limitations for the current study. The cross-sectional design makes it difficult to distinguish cause from effect. Moreover, although the effect sizes are strong, the limited sample size calls for replications in larger independent samples. Strengths of the current study includes a well characterized patient sample that has been characterized with research assessment by one psychiatrist for 12 years, 3 T high quality dMRI acquisition, validated and robust analysis methods.
To conclude, this study provides further evidence for white matter abnormalities, as well as evidence 
